Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-04-27 Sale | 2020-04-29 7:00 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 181 | $85.95 | $15,557 | 17,140 (Direct) | View |
| 2020-02-27 Sale | 2020-02-28 7:00 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 113 | $87.62 | $9,901 | 17,367 (Direct) | View |
| 2020-01-27 Sale | 2020-01-27 7:01 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 723 | $94.04 | $67,991 | 25,737 (Direct) | View |
| 2019-12-27 Sale | 2019-12-30 7:01 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 1,581 | $123.24 | $194,842 | 34,753 (Direct) | View |
| 2019-11-27 Sale | 2019-12-02 7:00 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 1,040 | $101.65 | $105,716 | 36,334 (Direct) | View |
| 2019-11-25 Sale | 2019-11-27 7:00 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 6,228 | $100 | $622,800 | 64,076 (Direct) | View |
| 2019-11-19 Sale | 2019-11-19 7:01 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 1,550 | $85 | $131,750 | 15,759 (Direct) | View |
| 2019-11-13 Sale | 2019-11-15 7:01 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 946 | $85 | $80,410 | 17,309 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-01 Tax Withholding | 2021-04-05 7:03 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 46 | $24.28 | 27,341 (Direct) | View |
| 2021-02-27 Tax Withholding | 2021-03-02 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $21.66 | 27,387 (Direct) | View |
| 2021-01-22 Option Award | 2021-01-26 7:02 pm | N/A 2031-01-22 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 32,300 | $0 | 47,444 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 7:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 833 | $24.7 | 15,144 (Direct) | View |
| 2020-11-27 Tax Withholding | 2020-11-30 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $37.27 | 15,977 (Direct) | View |
| 2020-10-01 Tax Withholding | 2020-10-05 7:02 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 46 | $42.08 | 16,334 (Direct) | View |
| 2020-08-27 Tax Withholding | 2020-08-31 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $48.81 | 16,380 (Direct) | View |
| 2020-07-01 Tax Withholding | 2020-07-06 7:03 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 46 | $46.52 | 16,737 (Direct) | View |
| 2020-05-27 Tax Withholding | 2020-05-29 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $74.43 | 16,783 (Direct) | View |
| 2020-04-01 Tax Withholding | 2020-04-03 7:08 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 46 | $58.4 | 17,321 (Direct) | View |
| 2020-02-27 Tax Withholding | 2020-02-28 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $85.39 | 17,367 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-27 7:01 pm | N/A 2030-01-23 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 12,700 | $0 | 25,737 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 418 | $123.92 | 13,760 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-30 7:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 416 | $59.12 | 34,753 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-30 7:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 54 | $58.74 | 34,753 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-30 7:01 pm | N/A 2027-11-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 470 | $0 | 34,753 (Direct) | View |
| 2019-11-27 Exercise | 2019-12-02 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 875 | $59.12 | 36,334 (Direct) | View |
| 2019-11-27 Exercise | 2019-12-02 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 52 | $58.74 | 36,334 (Direct) | View |
| 2019-11-27 Tax Withholding | 2019-12-02 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $109.16 | 36,334 (Direct) | View |
| 2019-11-27 Exercise | 2019-12-02 7:00 pm | N/A 2027-11-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 927 | $0 | 36,334 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-27 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 6,017 | $59.12 | 64,076 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-27 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 211 | $58.74 | 64,076 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-27 7:00 pm | N/A 2027-11-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 6,228 | $0 | 64,076 (Direct) | View |
| 2019-10-01 Tax Withholding | 2019-10-03 7:02 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 46 | $65.87 | 18,255 (Direct) | View |
| 2019-08-27 Tax Withholding | 2019-08-29 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $60.5 | 18,301 (Direct) | View |
| 2019-07-01 Tax Withholding | 2019-07-03 5:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 46 | $79.17 | 18,658 (Direct) | View |
| 2019-05-27 Tax Withholding | 2019-05-29 7:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development | 357 | $87.83 | 18,704 (Direct) | View |